Related Experiment Video
Updated: Jun 13, 2026
03:01
Improved Hysteroscopic Resection of Endometrial Polyps Using 6-Fr Micro-Scissors and Forceps
Published on: August 2, 2024
Are endometrial polyps true cancer precursors?
Tamar Perri1, Kurosh Rahimi, Agnihotram V Ramanakumar
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Jewish General Hospital, Montreal, Quebec, Canada.
American Journal of Obstetrics and Gynecology
|May 19, 2010
Summary
Endometrial polyps (EMPs) do not appear to be cancer precursors. Higher endometrial cancer (EmCa) detection in women with EMPs is likely due to increased screening opportunities, not a precursor relationship.
Area of Science:
- Gynecology
- Oncology
- Pathology
Background:
- Endometrial polyps (EMPs) are common gynecological findings.
- The potential for EMPs to be precursors to endometrial cancer (EmCa) remains unclear.
- Uterine leiomyomata serve as a control group for comparison due to their unrelatedness to endometrial carcinogenesis.
Purpose of the Study:
- To investigate whether endometrial polyps (EMPs) function as precursors to endometrial cancer (EmCa).
- To compare the incidence of EmCa in women with EMPs versus women with uterine leiomyomata.
Main Methods:
- Age-standardized incidence ratios (SIRs) for histologically verified EmCa were calculated.
- Data were compared between women diagnosed with EMPs and women with uterine leiomyomata.
- SIRs were determined by comparing observed EmCa cases to expected rates based on population data.
Main Results:
- Endometrial cancer (EmCa) was found in 8.5% of women with EMPs and 11.7% of women with uterine leiomyomata.
- The SIR of EmCa for women with EMPs (OR, 8.0) was significantly lower than for women with leiomyomata (OR, 19.1).
- Abnormal uterine bleeding was the primary indication for evaluating patients with EMPs.
Conclusions:
- The observed higher incidence of EmCa in women with EMPs is attributed to enhanced detection opportunities.
- Findings suggest EMPs are not precursors to endometrial cancer.
- Further research may clarify the relationship between EMPs and endometrial health.
More Related Videos
Related Concept Videos
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.